| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 4 |
| 1 | DOXORUBICIN | 4 |
| 2 | METHOTREXATE | 3 |
| 3 | METHOTREXATE SODIUM | 3 |
| 4 | TRASTUZUMAB | 3 |
| 5 | CYCLOPHOSPHAMIDE | 2 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 8 | IFOSFAMIDE | 2 |
| 9 | IFOSFAMIDE FOR INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0011 |
| 1 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 2 | BICALUTAMIDE | 1 | 0.0001 |
| 3 | MERCAPTOPURINE | 1 | 0.0001 |
| 4 | CISPLATIN | 4 | 0.0001 |
| 5 | DOXORUBICIN | 4 | 0.0000 |
| 6 | TRASTUZUMAB | 3 | 0.0000 |
| 7 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 1 | 0.0000 |
| 8 | PERTUZUMAB | 1 | 0.0000 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |
| 1 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 4 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |